Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash share-based compensation expenses of $505 and $1,276, respectively) 1,068 1,838
General and administrative expenses (including non-cash share-based compensation expenses of $558 and $1,078, respectively) 1,488 2,042
Total operating costs and expenses 2,556 3,880
Loss from operations (2,556) (3,880)
Interest income 202 1
Net loss (2,354) (3,879)
Less: Net loss attributable to noncontrolling interest (32) (50)
Net loss attributable to common shareholders $ (2,322) $ (3,829)
Net loss per common share attributable to common shareholders:    
Basic and diluted $ (0.08) $ (0.13)
Weighted average common shares outstanding:    
Basic and diluted 30,921 30,125